244
23
11
212
1
Cat. No. | Product Name | ||
---|---|---|---|
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 237 compounds | |
237 个Wnt & Hedgehog & Notch 靶点相关的生物活性小分子化合物的特有集合,用于相关通路的研究及药物的筛选,可用于高通量、高内涵筛选。 | |||
L2192 | 抗胰腺癌化合物库 | 2238 compounds | |
2238 种与胰腺癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L2191 | 抗乳腺癌化合物库 | 1939 compounds | |
1939 种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; | |||
L2196 | 抗卵巢癌化合物库 | 1867 compounds | |
1867 种与卵巢癌相关的化合物,可以用于抗卵巢癌药物研发和药理研究 | |||
L3700 | JAK-STAT 化合物库 | 252 compounds | |
252 个 JAK/STAT 靶点相关的小分子化合物的独特集合,用于高通量、高内涵筛选; | |||
L8300 | 染色质修饰分子库 | 250 compounds | |
250 种染色质化学修饰相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L9000 | 细胞凋亡化合物库 | 1760 compounds | |
1760 种与凋亡相关的生物活性小分子化合物的特有集合,多用于研究肿瘤发生发展机制和抗癌药物筛选等。可用于高通量筛选和高内涵筛选; | |||
L9700 | 内质网应激化合物库 | 193 compounds | |
193 个内质网应激相关的化合物集合,可用于高通量和高内涵筛选; | |||
L7100 | 抗肥胖化合物库 | 2247 compounds | |
2247 个抗肥胖化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2190 | 抗肺癌化合物库 | 1702 compounds | |
1702 种与肺癌相关的化合物,可以用于抗肺癌药物研发和药理研究; | |||
L8500 | HIF-1化合物库 | 1336 compounds | |
1336 个HIF-1相关小分子的独特集合,可用于缺血性疾病、癌症等相关领域的药物开发和药理研究; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8890 |
653-47 hydrochloride
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
653-47 hydrochloride 是一种增强剂,能显著增强 666-15 的 cAMP 反应元件结合蛋白 (CREB) 抑制活性。它也是 CREB 抑制剂,IC50为 26.3 μM。 | |||
T7589 |
Afamelanotide acetate
afamelanotide |
Melanocortin Receptor | GPCR/G Protein; Neuroscience |
Afamelanotide acetate 是一种合成的 α-黑素细胞刺激激素类似物和一流的黑皮质素-1 受体激动剂,用于治疗红细胞生成性原卟啉症。 | |||
T13044 |
Mevociclib
SY-1365 |
CDK | Cell Cycle/Checkpoint |
Mevociclib (SY-1365) 是一种高效选择性 CDK7抑制剂,Ki 值为 17.4 nM。它具有抗血液肿瘤和侵袭性实体肿瘤作用,有抗增殖和凋亡活性。 | |||
T12075 |
ML-180
SR1848 |
Others | Others |
ML-180 (SR1848) 是孤儿核受体肝受体同源物 1 (LRH-1;NR5A2) 的反向激动剂(IC50:3.7 µM)。它不抑制类固醇生成因子 1 (SF-1;NR5A1; IC50>10 µM)。 它具有潜在的抗依赖 LRH-1 癌症作用。 | |||
T2455 |
PFK-015
PFK15,PFK 015 |
Glucokinase; Autophagy | Autophagy; Metabolism |
PFK-015 (PFK15) 是一种有效的 PFKFB3 抑制剂,对重组PFKFB3的IC50为110 nM。它能抑制 Y 细胞中的 PFKFB3 活性,IC50为20 nM。 | |||
T8740 |
COH-SR4
COH-SR4 (Mitochondria uncoupler SR4) |
Others; AMPK | Chromatin/Epigenetic; Others; PI3K/Akt/mTOR signaling |
COH-SR4 (COH-SR4 (Mitochondria uncoupler SR4)) 是线粒体氧化磷酸化的解偶联剂,可调节 amp 依赖性激酶 (ampk)-雷帕霉素 (mtor) 信号的哺乳动物靶点,并抑制 hepg2 肝癌细胞的增殖。它对白血病、黑色素瘤、乳腺癌和肺癌显示出强大的抗增殖活性。它是一种AMPK 活化剂,通过激活 AMPK 来抑制脂肪细胞分化,可用于肥胖及代谢紊乱相关的研究。 | |||
TP1097 |
Melanotan I
美拉诺坦,美拉诺坦 I,[Nle4,D-Phe7]-α-MSH,Afamelanotide,MT-I |
Others | Others |
Melanotan I 是一种非特异性黑素皮质激素受体 (MCR) 激动剂, 是一种 α- 黑素细胞刺激激素 (α-MSH) 类似物,皮下注射可增加黑色素在皮肤中的含量。Melanotan I 可用于辅助美黑。Melanotan I 可用于预防阳光诱发皮肤癌,可用于研究黑色素瘤和男性勃起功能障碍。 | |||
T5349 |
SCR-1481B1
麦他替尼胺丁三醇,c-Met inhibitor 2 |
VEGFR; c-Met/HGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
SCR-1481B1 (c-Met inhibitor 2) 能够作用于依赖 Met 激活的癌症,对 VEGFR 具有抑制作用。 | |||
T7598 |
Calcium N5-methyltetrahydrofolate
5-甲基四氢叶酸钙,N5-甲基四氢叶酸钙,NSC173328 |
Others; Antifolate | Cell Cycle/Checkpoint; Others |
Calcium N5-methyltetrahydrofolate (NSC-173328) 是左旋叶酸的钙盐,用于治疗心血管疾病、乳腺癌和结肠直肠癌。 | |||
T9806 |
NVP-DKY709
|
Others | Others |
NVP-DKY709 是一种有效的 IKZF2 抑制剂,用于治疗癌症。 | |||
T9089 |
FTO-IN-1
UUN44923 |
Others | Others |
UUN44923 是脂肪及肥胖相关酶(FTO) 抑制剂(IC50<1 μM)。其中FTO-IN-1 (UUN44923) 可用于研究癌症。 | |||
T27454 |
GSK2008607
|
Raf | MAPK |
GSK2008607是 一种有效的 B-RafV600E 抑制剂,具有抗癌活性,可用来研究乳腺癌、结直肠癌、黑色素瘤、甲状腺癌、卵巢癌。 | |||
T37422L |
Ras Inhibitory Peptide acetate
Ras Inhibitory Peptide acetate(159088-48-9 Free base) |
Ras | GPCR/G Protein; MAPK |
Ras Inhibitory Peptide acetate 是一种参与 Ras 依赖性信号通路的肽,Ras 在致癌受体引发的人类癌症中起重要作用。 | |||
T9175 |
Casein Kinase inhibitor A51
|
Apoptosis; Casein Kinase | Apoptosis; Metabolism; Stem Cells |
Casein Kinase inhibitor A51 是一种具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂,具有抗癌活性,可诱导白血病细胞凋亡 (apoptosis),可用于研究颈部癌、急性髓系白血病、乳腺癌和前列腺癌。 | |||
T39640 |
JAB-3068
SHP2-IN-6 |
Phosphatase | Metabolism |
JAB-3068 (SHP2-IN-6) 是一种高效的 SHP2 抑制剂, 具有抗癌抗肿瘤活性,可用于研究乳腺癌肺癌和食道癌。 | |||
T63351L |
MS8511 HCl
MS8511 HCl(2866408-21-9 Free base) |
Histone Methyltransferase | Chromatin/Epigenetic |
MS8511 HCl 是一种具有选择性和有效性的 G9a/GLP 共价抑制剂,通过靶向底物结合位点的半胱氨酸残基发挥作用。 MS8511 具有抗癌活性和抗增殖活性,可降低细胞内 H3K9me2 水平。MS8511 可用于研究包括脑癌、乳腺癌、卵巢癌在内的多种癌症。 | |||
T15018 |
CUDC-427
GDC-0917 |
IAP | Apoptosis |
CUDC-427 (GDC-0917) 是一种具有口服生物活性的泛拮抗剂,是凋亡蛋白抑制剂 (IAP) 的拮抗剂。 CUDC-427 可用于癌症研究。 | |||
T70121 |
Zavondemstat
TACH 101 free base,QC8222 free base |
Histone Demethylase | Chromatin/Epigenetic |
Zavondemstat (QC8222 free base) 是一种组蛋白赖氨酸去甲基化酶4 (KDM4) 抑制剂,具有抗癌抗肿瘤活性,可用于研究三阴癌和乳腺癌。 | |||
T12365 |
PARP/PI3K-IN-1
|
PARP; PI3K | Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
PARP/PI3K-IN-1 是一种 新型双重聚(ADP-核糖)聚合酶(PARP)和磷酸肌醇 3-激酶(PI3K)双重抑制剂,具有抗癌、抗肿瘤和抗癌细胞增殖活性,可用于研究乳腺癌、胰腺癌和肺癌。 | |||
T2477 |
UNBS5162
UNBS 5162,UNBS-5162 |
CXCR; Autophagy | Autophagy; GPCR/G Protein; Immunology/Inflammation |
UNBS5162 (UNBS-5162) 是一种新型萘酰亚胺,可降低实验性前列腺癌中 CXCL 趋化因子的表达。它是一种广谱趋化因子配体CXCL 拮抗剂,具有抗肿瘤活性。 | |||
T9531 |
MRT-14
|
Smo | Stem Cells |
MRT-14 是有效的 Smo 拮抗剂。Smo 是参与 Hedgehog 形态发生素信号转导的主要成分。MRT-14 在研究与异常 Hh 信号传导相关的多种癌症方面有价值。 | |||
T84287 |
P3FI-63
|
Histone Demethylase | Chromatin/Epigenetic |
P3FI-63 是一种选择性 KDM3B 抑制剂(IC50:7 μM),具有抗肿瘤活性,可用于研究融合阳性横纹肌肉瘤和其他转录成瘾癌症。 | |||
T77448 |
Naxitamab
Naxitamab-gqgk,Humanized 3F8,Hu3F8 |
Others | Others |
Naxitamab (Hu3F8) 是一种针对二氮冈糖苷 GD2 (hu3F8)的人源化单克隆抗体。Naxitamab 具有抗肿瘤活性,可用于研究神经母细胞瘤、骨肉瘤和其他 GD2 阳性癌症。 | |||
T60542 |
BTK-IN-16
|
BTK | Angiogenesis; Tyrosine Kinase/Adaptors |
BTK-IN-16 是一种潜在的野生型 BTK 和 C481S 突变体的抑制剂。BTK-IN-16 可用于研究由BTK 引起的各种自身免疫性疾病和癌症。 | |||
T73494 |
TNG908
|
Histone Methyltransferase | Chromatin/Epigenetic |
TNG908 是一种可通过血脑屏障且具有口服活性和选择的 MTAP 协同 PRMT5 抑制剂,可杀死对MTAP缺失的癌症。 | |||
T24610 |
Pegamotecan
Prothecan,PEG-camptothecin,PEG-beta-CPT |
Topoisomerase | DNA Damage/DNA Repair |
Pegamotecan (PEG-camptothecin)是一种拓扑异构酶I(TOP1)抑制剂,具有抗癌活性,它可用于治疗食管癌、非小细胞肺癌和胰腺癌。 | |||
T9585 |
GNE-9815
3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide |
Raf | MAPK |
GNE-9815 (3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide) 是一种高激酶选择性 RAF 抑制剂,可用于通过联合治疗靶向 KRAS 突变癌症。 | |||
T72107 |
Werner syndrome RecQ helicase-IN-1
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Werner syndrome RecQ helicase-IN-1 是一种有效的 Werne r 综合征 RecQ DNA 解旋酶 (WRN) 抑制剂,可用研究像结肠癌和胃癌等癌症。 | |||
T2503 |
PAC-1
Procaspase activating compound 1 |
Apoptosis; Caspase; Autophagy | Apoptosis; Autophagy; Proteases/Proteasome |
PAC-1 (Procaspase activating compound 1) 是一种 procaspase-3激活剂,诱导癌细胞凋亡,EC50为 2.08 μM,可用于研究淋巴瘤、黑色素瘤、实体瘤、乳腺癌和胸癌等治疗的试验。 | |||
T13572 |
Cancer-Targeting Compound 1
|
Others | Others |
Cancer-Targeting Compound 1可用于激素相关癌症的研究,包括治疗或预防肌瘤、子宫平滑肌瘤、多囊卵巢综合征或激素依赖性癌等等。 | |||
T76696 |
Onvatilimab
JNJ-61610588 |
Others | Others |
Onvatilimab (JNJ-61610588) 是一种人 IgG1κ 抗 VISTA (T 细胞激活的 V 域 Ig 抑制剂) 单克隆抗体。Onvatilimab 具有抗肿瘤活性,可用于治疗晚期头颈癌。 。 | |||
T26704 |
AZ13705339
AZ-13705339,AZ 13705339 |
PAK | Cytoskeletal Signaling |
AZ13705339 是一种有效的 PAK1 抑制剂,IC50 为 0.33 nM,Kd 为 0.28 nM。 AZ13705339 以 0.32 nM 的 Kd 结合 PAK2。 AZ13705339 可用于癌症研究。 | |||
T61931 |
IRAK4-IN-10
|
IRAK | Immunology/Inflammation; NF-κB |
IRAK4-IN-10 是一种高效的 IRAK4 抑制剂(IC50:1.5 nM),具有潜在的抗癌和抗炎活性。IRAK4-IN-10 阻断 MyD88 信号传导,可用研究自身免疫性疾病和癌症。 | |||
T61304 |
FGFR2-IN-1
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR2-IN-1是一种 FGFR 抑制剂,对 FGFR1、FGFR2和FGFR3具有抑制作用, IC50 分别为460、140和2200 nM。FGFR2-IN-1 可用于研究与 FGFR2 相关的癌症。 | |||
T9141 |
ERK-IN-3
ASN007 free base |
ERK | MAPK |
ERK-IN-3 (ASN007 free base) 是一种有效的口服活性 ERK 抑制剂,以低 IC50 值抑制 ERK1/2,可用于研究由 RAS 突变驱动的癌症。 | |||
T60039 |
KSQ-4279
USP1-IN-1 |
PARP; DUB | Cell Cycle/Checkpoint; Chromatin/Epigenetic; DNA Damage/DNA Repair; Ubiquitination |
KSQ-4279 (USP1-IN-1)是 USP1 和 PARP 的抑制剂。KSQ-4279 具有抗癌活性,可用于研究非小细胞肺癌、骨肉瘤、卵巢癌、乳腺癌、胶质母细胞瘤、膀胱癌、子宫癌和胰腺癌。 | |||
T61318 |
BRD4 Inhibitor-20
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
BRD4 Inhibitor-20是一种有效的溴结构域蛋白4(BRD4)抑制剂,具有口服活性。BRD4 Inhibitor-20在癌细胞系中具有抗增殖活性,并被用于各种癌症的研究,如结肠癌。 | |||
T77466 |
Tremelimumab
Ticilimumab,CP-675206 |
Others | Others |
Tremelimumab 是一种细胞毒性T淋巴细胞相关抗原-4(CTLA-4)阻断抗体.Tremelimumab 常与 Durvalumab 联合使用来治疗肝癌、肺癌等实体癌。 | |||
T36646 |
Trastuzumab deruxtecan
DS-8201a,VRN-101099,DS 8201,T-DXd |
Others; Antibody-Drug Conjugates (ADCs) | Antibody-drug Conjugate/ADC Related; Others |
Trastuzumab deruxtecan (T-DXd) 是一种具有抗癌抗肿瘤活性的抗体-活性分子偶联物 (ADC)。Trastuzumab deruxtecan 对 HER2 阳性乳腺癌和胃癌有改善作用。 | |||
T6341 |
PF04929113
PF-04929113,SNX-5422,PF 04929113 |
HSP; HER | Angiogenesis; Cytoskeletal Signaling; JAK/STAT signaling; Metabolism; Tyrosine Kinase/Adaptors |
PF04929113 (SNX-5422) 是一种合成的新型小分子 Hsp90 抑制剂。作为一种具有强大疗效和耐受性的口服制剂,它被定位为一种突破性疗法,在广泛的癌症中具有广泛的适用性。 | |||
T67703 |
mTOR inhibitor 9b
|
mTOR | PI3K/Akt/mTOR signaling |
mTOR inhibitor 9b 是一种酶抑制剂,对蛋白激酶mTOR 和磷脂酰肌醇 3-激酶 PIK3CA 具有抑制作用,IC50分别为 0.76nm 和1.262 µM。mTOR inhibitor 9b 具有抗癌活性,可用来研究白血病、皮肤癌、乳腺癌、肺癌和结肠癌。 | |||
T36821 |
FQI 1
FQI1,FQI-1 |
Others | Others |
FQI 1 是一种选择性晚期 SV40 因子 (LSF) 抑制剂,具有抗癌活性,通过破坏有丝分裂纺锤体发挥抗增殖活性。FQI 1 抑制 NIH/3T3、HeLa、A549 细胞增殖,可用于研究癌症。 | |||
T85316 |
ADT-007
ADT 007,ADT007 |
Ras | GPCR/G Protein; MAPK |
ADT-007 是一种具有口服活性和选择性的泛 RAS 抑制剂,具有很强的抗癌活性。ADT-007 通过结合无核苷酸 RAS 以阻断 RAS 和 MAPK/AKT 信号传导的 GTP 激活。ADT-007 可用于研究胃肠道癌。 | |||
T62447 |
Paltimatrectinib
PBI-200,PPI-5278 |
Trk receptor; Tyrosine Kinases | Tyrosine Kinase/Adaptors |
Paltimatrectinib (PBI-200) 是一种高效的酪氨酸激酶 (tyrosine kinase) 抑制剂,具有抗癌活性,抑制肌球蛋白相关激酶 A (TrkA) 。Paltimatrectinib 可用于研究膀胱癌、乳腺癌和结直肠癌。 | |||
T77405 |
Enfortumab
|
Others; ADC Antibody | Antibody-drug Conjugate/ADC Related; Others |
Enfortumab 是一种针对 Nectin-4 的单克隆抗体。Enfortumab 可用于合成抗体-药物偶联物(enfortumab vedotin),也可用于和铂类化合物一起连用研究尿路上皮癌。 | |||
T72553 |
ARTD10/PARP10-IN-1
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
ARTD10/PARP10-IN-1 是一种强效性的 PARP 抑制剂,抑制单 ADP 核糖转移酶 ARTD7/PARP15,ARTD8/PARP14,ARTD10/PARP10 和聚 ADP-核糖聚合酶-1 (ARTD1/PARP1),具有潜在的抗癌抗肿瘤活性,可用于研究前列腺癌和乳腺癌。 | |||
T36648 |
Tucatinib hemiethanolate
ONT-380 hemiethanolate,ARRY-380 hemiethanolate,Irbinitinib hemiethanolate |
HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tucatinib hemiethanolate (Irbinitinib hemiethanolate) 是一种具有口服活性、选择性和高效性的靶向人表皮生长因子受体2(HER2)的酪氨酸激酶抑制剂,具有抗癌活性,可用于研究转移性HER2阳性乳腺癌和结直肠癌。 | |||
T78211 |
STX-478
|
PI3K | PI3K/Akt/mTOR signaling |
STX-478 是一种能穿透血脑屏障且具有口服活性和选择性的 PI3Kα抑制剂,具有抗癌活性,可抑制肿瘤生长。STX-478适用于研究乳腺癌和其他癌症。 | |||
T4169 |
N-Nitroso-N-methylurea
1-甲基-1-亚硝基脲,1-Methyl-1-nitrosourea,N-Methyl-N-nitrosourea,Methylnitrosourea |
Others; DNA Alkylator/Crosslinker | DNA Damage/DNA Repair; Others |
N-Nitroso-N-methylurea 是一种具有烷基化、致癌和致突变特性的亚硝基脲化合物。它靶向多种动物器官,可引起各种癌症和变性疾病,可用于重氮甲烷合成。 | |||
T76766 |
Mirvetuximab
M9346A |
Antifolate | Cell Cycle/Checkpoint |
Mirvetuximab (M9346A) 是一种新型叶酸受体α (FRα) 靶向 anti-FOLR1 (folate receptor 1) 的单克隆抗体。Mirvetuximab soravtansine 常与铂类化合物或与其他化合物偶联成为抗体-药物偶联物用来治疗卵巢癌和其他 FRα 阳性的癌症。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8343 |
8-Hydroxy-2'-deoxyguanosine
8-OHdG,8-Hydroxydeoxyguanosine,8-Hydroxy-2-Deoxyguanosine,2'-Deoxy-8-oxoguanosine,8 OHdG,8-Oxo-dG,8-OH-脱氧鸟嘌呤,8 Oxo dG,8-Oxo-2'-deoxyguanosine |
Endogenous Metabolite | Metabolism |
8-Hydroxy-2'-deoxyguanosine (8-OHdG) 是致癌反应和氧化应激的关键生物标志物。 | |||
T5656 |
(±)-Norcantharidin
Endothall anhydride,去甲斑蝥素,Norcantharidin |
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
(±)-Norcantharidin (Endothall anhydride) 是一种人类结肠癌中 c-Met 和 EGFR 的双重抑制剂,可研究抗癌,具有抗血管生成活性。 | |||
T2894 |
Norcantharidin
Norcantharadine,去甲斑蝥素,Endothall anhydride |
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Norcantharidin (Norcantharadine) 是一种合成的抗癌化合物,是人类结肠癌中 c-Met 和 EGFR 的双重抑制剂。 | |||
T9605 |
Sangivamycin
BA-90912,桑霉素,NSC 65346 |
Nucleoside Antimetabolite/Analog; PKC | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair |
Sangivamycin (NSC-65346) 是蛋白激酶 C (PKC) 的有效抑制剂 (Ki = 10 μM)。 Sangivamycin 对多种人类癌症细胞具有抗增殖活性。 | |||
TQ0295 |
Coumestrol
拟雌内酯,考迈斯托醇 |
Estrogen Receptor/ERR | Endocrinology/Hormones |
Coumestrol 是一种大豆产品中存在的植物雌激素。它抑制ES2细胞增殖的IC50值为50 μM。它可用于癌症,神经障碍和自身免疫疾病的研究。 | |||
T7883 |
Proanthocyanidins
Procyanidin |
Antibacterial; Antifungal | Microbiology/Virology |
Proanthocyanidins 是一类在高等植物中广泛分布的多酚化合物,用作抗氧化剂和抗癌剂。它可研究慢性静脉功能不全、毛细血管脆弱、晒伤和视网膜病变,有抗炎、抗菌、抗真菌和保护心脏的特性。 | |||
T15705 |
Laminaran
β-1,3-Glucan |
||
Laminaran 是一种从褐藻中分离出来的 β-1-3-葡聚糖,常作为 Dectin-1 的典型配体,具有抗癌、免疫调节和辐射防护作用。 Laminaran 可被葡糖酶催化。Laminaran 在体内外实验中显示出抗肿瘤活性,可用于预防和治疗癌症。 | |||
TN3628 |
Chamaejasmenin B
|
Others | Others |
Chamaejasmenin B 是一种从 Stellera chamaejasme L 中分离得到的化合物。Chamaejasmenin B 具有抗癌和抗肿瘤活性,可抑制癌细胞迁移和侵袭,抑制肿瘤转移。Chamaejasmenin B 可用于研究如乳腺癌类的癌症。 | |||
T6S1683 |
Demethoxycurcumin
Curcumin II,去甲氧基姜黄素,Desmethoxycurcumin,脱甲氧姜黄,Monodemethoxycurcumin |
Apoptosis; Antioxidant; Antibacterial; Autophagy | Apoptosis; Autophagy; Microbiology/Virology; oxidation-reduction |
Demethoxycurcumin (Desmethoxycurcumin) 是姜黄素的主要活性成分,有抗炎和抗癌作用。 | |||
TN1673 |
Garcinone C
伽升沃 C,伽升沃C |
ATM/ATR; CDK; STAT; AChR; Antifection | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; JAK/STAT signaling; Microbiology/Virology; Neuroscience; PI3K/Akt/mTOR signaling; Stem Cells |
Garcinone C 是一种从 Garcinia oblongifolia Champ 中提取的黄酮衍生物,具有抗炎、收敛和促进肉芽的活性。 Garcinone C 是一种 AChE 抑制剂,对某些癌症具有潜在的细胞毒性作用。 | |||
T5530 |
Mithramycin A
Plicamycin |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Mithramycin A (Plicamycin) 是一种dna 结合的抗肿瘤抗生素,选择性特异性蛋白1 (Sp1)抑制剂,通过降低Sp1蛋白抑制多种肿瘤的生长。特异性蛋白1 (Sp1)是一种锌指转录因子,调节多种细胞功能,促进肿瘤进展。 | |||
T1181 |
Gefitinib
ZD1839,吉非替尼 |
EGFR; Tyrosine Kinases; Autophagy | Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Gefitinib (ZD1839) 是一种 EGFR 一代抑制剂,具有口服活性,抑制 EGFR 19 Del 和 L858R 突变。Gefitinib 具有抗肿瘤活性,用于治疗 EGFR 突变的非小细胞肺癌。Gefitinib 用药会产生 EGFR C797S 耐药突变。 | |||
TN1019 |
Beta-mangostin
β-Mangostin,beta-倒捻子素 |
Apoptosis; Antibacterial; Parasite | Apoptosis; Microbiology/Virology |
Beta-mangostin (β-Mangostin) 是存在 Cratoxylum arborescens 中的一种氧杂蒽酮类天然产物,有抗癌和抗菌活性,对结核分枝杆菌的 MIC 值为 6.25 μg/mL。它在体外有抗疟活性,对恶性疟原虫的 IC50值为 3.00 μg/mL。 | |||
T3S0209 |
Vincristine
|
ERK; p38 MAPK; NF-κB; Akt; JNK; mTOR | Cytoskeletal Signaling; MAPK; NF-κB; PI3K/Akt/mTOR signaling |
Vincristine 属于生物碱类天然产物,可与微管蛋白结合并抑制微管的形成,从而抑制肿瘤细胞的有丝分裂。Vincristine 可用作微管去稳定剂,用于研究治疗血液系统肿瘤,如白血病和淋巴瘤以及儿童肉瘤的相关研究。 | |||
T3S0027 |
Picropodophyllotoxin
AXL 1717,Picropodophyllin,苦鬼臼毒素 |
IGF-1R | Tyrosine Kinase/Adaptors |
Picropodophyllotoxin (AXL 1717) 是一种环木脂素生物碱,存在于五月树(Podophyllum peltatum) 中,是一种具有潜在抗肿瘤活性的胰岛素样生长因子 1 受体 (IGF1R) 的小分子抑制剂。它特异性抑制 IGF1R 的活性并下调细胞表达,而不干扰其他生长因子受体的活性,例如胰岛素受体、表皮生长因子、血小板衍生生长因子、成纤维细胞生长因子和肥大/干细胞生长因子 (KIT) )。该药剂在抑制肿瘤细胞增殖和诱导肿瘤细胞凋亡方面显示出有效的活性。 IGF1R 是一种在多种人类癌症中过度表达的受体酪氨酸激酶,在多种癌细胞的生长和存活中起关键作用。 | |||
T13933 |
Toringin
|
Others | Others |
Toringin is a bioflavonoid isolated from the bark of Docyniopsis tschonoski, and have various biological activities and beneficial actions against cancers, coronary heart disease, among other pathologies. | |||
T21523 |
β-Tocotrienol
Beta-Tocotrienol |
Caspase | Apoptosis; Proteases/Proteasome |
Beta-Tocotrienol to serve as a new anticancer agent for treating human lung and brain cancers. It inhibits the growth of both A549 (GI50=1.38±0.334μM) and U87MG (GI50=2.53±0.604μM) cells at rather low concentrations. | |||
T66903 |
Gallic Acid Monohydrate
|
Others | Others |
Gallic acid may be used as a standard in the photometric determination of total phenolics content by Folin-Ciocalteu method with potential role in epigenetic therapy of human cancers. | |||
T75637 |
Demethylcantharidate disodium
|
Others | Others |
Demethylcantharidate disodium 是一种内源性代谢产物,能通过诱导内质网应激来促进肝癌细胞的凋亡,并且对多种类型的癌症展现出良好的抗癌活性。 | |||
T80702 |
α-Thevetin B
|
||
α-Thevetin B(Compound 24), 一种从Thevetia peruviana分离得到的心脏苷,用于肺癌、胃癌和胰腺癌的研究。 | |||
T32162 |
Ingenol disoxate
LEO-43204,LEO43204,LEO 43204 |
Others | Others |
Ingenol disoxate, also known as LEO43204, is a Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers. Ingenol is a natural product found in the sap of the plant Euphor | |||
T72802 |
Spongionellol A
|
Others | Others |
Spongionellol A 是一种 MDR1(p-糖蛋白) 抑制剂。Spongionellol A 通过诱导 caspase 依赖性的凋亡 (apoptosis) 而对前列腺癌细胞具有较强的细胞毒活性和选择性。Spongionellol A 可用于癌症的研究,如前列腺癌。 | |||
T74368 |
OKI-006
|
Others | Others |
OKI-006 是一种有效的、具有口服活性的组蛋白脱乙酰酶 (HDAC) 抑制剂。OKI-006 是天然产物HDAC 抑制剂 largazole 的独特同系物。组蛋白去乙酰化酶 (HDAC) 在表观基因组调控中起关键作用,并且组蛋白乙酰化在许多人类癌症中失调。OKI-006 具有研究癌症疾病的潜力。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05030 |
PCDH7 Protein, Human, Recombinant (His)
BHPCDH |
Human | Baculovirus Insect Cells |
PCDH7, a member of protocadherins family, functions as tumor suppressor in several human cancers. The human PCDH7 gene is localized in chromosome 4p15, which is often inactivated in human cancers, including bladder cancer. The low PCDH7 expression is a potential prognostic biomarker for primary non-muscle invasive bladder cancer (NMIBC). PCDH7 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 94 kDa and the accession number... | |||
TMPK-00811 |
L1CAM Protein, Mouse, Recombinant (His)
CALL,MGC132578,FLJ44930,NCAM-L1,MIC5,CHL-1,SPG1,HSAS,CD171,L... |
Mouse | HEK293 Cells |
L1 cell adhesion molecule (L1CAM) is one of the first neural adhesion molecules described with important functions in the development of the nervous system. Subsequent work discovered that L1CAM is expressed in many human cancers and is often associated with bad prognosis. This is most likely due to the motility and invasion promoting function of L1CAM. L1CAM is a valuable diagnostic/prognostic marker and an attractive target for the therapy of several human cancers. | |||
TMPY-02292 |
IGSF11 Protein, Human, Recombinant (His)
CT119,immunoglobulin superfamily, member 11,BT-IgSF,Igsf13,C... |
Human | HEK293 Cells |
Immunoglobulin superfamily member 11(IGSF11) is expressed on the plasma membrane in the testis and brain. These IGSF proteins undergo final modifications during capacitation and/or the acrosome reaction. IGSF proteins share significant homology with endothelial cell-selective adhesion molecule and coxsackievirus and adenovirus receptor, which mediates cell attachment and homotypic intercellular interactions. In clinical, the IGSF11 has been reported to overexpressed in colorectal cancers and hep... | |||
TMPK-00782 |
PLAU/uPA Protein, Mouse, Recombinant (His & Avi)
PLAU,UPA,BDPLT5,ATF,u-PA,QPD,Urokinase,URK |
Mouse | HEK293 Cells |
Plasminogen activator, urokinase (uPA) is a secreted serine protease whose Dysregulation is often accompanied by various cancers. PLAU inhibition could suppress tumor growth. Collectively, PLAU is necessary for tumor progression and can be a diagnostic and prognostic biomarker in HNSCC. PLAU/uPA Protein, Mouse, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 49.00 kDa and the accession number is P06869. | |||
TMPK-00008 |
CCL5 Protein, Mouse, Recombinant (hFc)
D17S136E,RANTES,SCYA5,SIS-δ,Ccl5,SISd,eoCP,MuRantes,TCP228,S... |
Mouse | HEK293 Cells |
The CCR5 and the CCL5 ligand have been detected in some hematological malignancies, lymphomas, and a great number of solid tumors, but extensive studies on the role of the CCL5/CCR axis were performed only in a limited number of cancers. CCL5 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with N-hFc tag. The predicted molecular weight is 35.2 kDa and the accession number is P30882. | |||
TMPY-02030 |
CD82 Protein, Human, Recombinant (His)
CD82 molecule,SAR2,R2,KAI-1,4F9,KAI1,C33,TSPAN27,ST6,IA4,GR1... |
Human | HEK293 Cells |
CD82, also known as KAI-1, structurally belongs to tetraspanin family while categorised as metastasis suppressor gene on functional grounds. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signalling. Downregulation of CD82 expression is associated with the advanced stages of many human cancers and correlates with the acquisition of metastatic potential. Recent stud... | |||
TMPY-02525 |
RGMA Protein, Human, Recombinant (His)
repulsive guidance molecule family member a,RGM |
Human | HEK293 Cells |
RGMa, also known as RGM domain family, member A, belongs to the RGM (repulsive guidance molecule) family whose members are membrane-associated glycoprotein. RGMa is a glycosylphosphatidylinositol-anchored glycoprotein that functions as an axon guidance protein in the developing and adult central nervous system. It helps guide Retinal Ganglion Cell (RGC) axons to the tectum in the midbrain. RGMa has been implicated to play an important role in the developing brain and in the scar tissue that form... | |||
TMPY-02801 |
PHGDH Protein, Human, Recombinant (His)
phosphoglycerate dehydrogenase,HEL-S-113,3PGDH,NLS1,PHGDHD,P... |
Human | E. coli |
PHGDH is a member of the D-isomer specific 2-hydroxyacid dehydrogenase family. This new family consists of D-isomer-stereospecific enzymes. The conserved residues in this family appear to be the residues involved in the substrate binding and the catalytic reaction, and thus to be targets for site-directed mutagenesis. A number of NAD-dependent 2-hydroxyacid dehydrogenases which seem to be specific for the D-isomer of their substrate have been shown to be functionally and structurally related. PH... | |||
TMPY-00117 |
FGF-16 Protein, Human, Cynomolgus, Recombinant
fibroblast growth factor 16 |
Human,Cynomolgus | Baculovirus Insect Cells |
Fibroblast growth factor 16 (FGF16) is preferentially expressed in the heart after birth, suggesting its regulation is associated with tissue-specific chromatin remodeling and DNA-protein interactions. Mutation of the MEF2 site resulted in a blunting of FGF16 promoter activity in transfected neonatal rat cardiac myocytes, that chromatin remodeling and MEF2 binding in the FGF16 promoter contribute to expression in the postnatal heart. FGF16 involvement in the fine tuning of the human skeleton of ... | |||
TMPY-01736 |
COX-2 Protein, Human, Recombinant (His)
GRIPGHS,PHS-2,hCox-2,COX-2,PGHS-2,prostaglandin-endoperoxide... |
Human | Baculovirus Insect Cells |
PTGS2, also known as COX-2, is s component of Prostaglandin-endoperoxide synthase (PTGS). PTGS, also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. PTGS2 is overexpressed in many cancers. The overexpression of PTGS2 along with increased angiogenesis and GLUT-1 expression ... | |||
TMPJ-00137 |
APRIL/TNFSF13 Protein, Human, Recombinant (Flag & His)
TRDL-1,TNF- and APOL-related leukocyte expressed ligand 2,Tu... |
Human | HEK293 Cells |
APRIL (a proliferation-inducing ligand), also known as TNFSF13, TALL2, TRDL1, and CD256, is a member of the TNF ligand superfamily. It is synthesized as a 32 kDa proprotein which is cleaved by furin in the Golgi to release the active 17 kDa soluble molecule. Secreted human APRIL, which consists almost entirely of a single TNF homology domain, shares 85% amino acid sequence identity with mouse and rat APRIL. Both APRIL and its close relative BAFF bind and signal through the TNF superfamily recept... | |||
TMPY-04830 |
GAS6 Protein, Mouse, Recombinant (His)
growth arrest-specific 6,Gas-6 |
Mouse | HEK293 Cells |
The growth arrest-specific 6 gene (GAS6) is a member of the family of plasma vitamin K-dependent proteins, which are able to bind to phospholipids using an N-terminal gamma-carboxyglutamic acid domain. GAS6 is a vitamin K-dependent protein, plays a role in the survival, proliferation, migration, differentiation, adhesion, and apoptosis of cells. The growth arrest-specific 6 (GAS6) has been implicated in systemic inflammation and coagulation. Growth arrest-specific 6 (GAS6), plays a role in tumor... | |||
TMPY-01442 |
DMBT1 Protein, Human, Recombinant (His)
GP340,deleted in malignant brain tumors 1,muclin |
Human | HEK293 Cells |
Deleted in malignant brain tumors 1 protein, also known as glycoprotein 34, surfactant pulmonary-associated D-binding protein, DMBT1 and GP34, is a secreted protein which belongs to theDMBT1 family. DMBT1 contains 2CUB domains, 14SRCR domains and 1ZP domain. It is highly expressed in alveolar and macrophage tissues. In some macrophages, expression is detected on the membrane, and in other macrophages, it is strongly expressed in the phagosome/phagolysosome compartments. Defects in DMBT1 are invo... | |||
TMPY-00150 |
IGF2/IGF-II Protein, Human, Recombinant
PP9974,胰岛素样生长因子,C11orf43,IGF-II,insulin-like growth factor 2 |
Human | P. pastoris (Yeast) |
Insulin-like growth factor 2 (IGF-2/IGF-II) is a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumor, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. IGF-2/IGF-II is a mediator of prolactin-induced alveologenesis; prolactin, IGF-2, and cyclin D1, all of which are overexpressed in br... | |||
TMPH-02213 |
Tomoregulin-1 Protein, Human, Recombinant (E. coli, His)
H7365,TMEFF1,Tomoregulin-1,Transmembrane protein with EGF-li... |
Human | E. coli |
May inhibit NODAL and BMP signaling during neural patterning. May be a tumor suppressor in brain cancers. | |||
TMPK-00828 |
Mucin-1/MUC1 Isoform Y Protein, Human, Recombinant (hFc)
PEMT,Episialin,Mucin1,PUM,KL-6,MUC-1,Mucin-1,H23AG,PEM,CA 15... |
Human | HEK293 Cells |
MUC1, the transmembrane glycoprotein Mucin 1, is usually found to be overexpressed in a variety of epithelial cancers playing an important role in disease progression. MUC1 isoforms such as MUC1/Y, which lacks the entire variable number of tandem repeat region, are involved in oncogenic processes by enhancing tumour initiation. MUC1/Y is therefore considered a promising target for the identification and treatment of epithelial cancers. | |||
TMPK-01081 |
Glypican 2/GPC2 Protein, Mouse, Recombinant (His)
Cerebroglycan,2410016G05Rik,GPC2,Glypican-2 |
Mouse | HEK293 Cells |
Glypicans can function as coreceptors for multiple signaling molecules known for regulating cell growth, motility, and differentiation. Some members of the glypican family, including glypican 2 (GPC2) and glypican 3 (GPC3), are expressed in childhood cancers and liver cancers, respectively. Antibody-based therapies targeting glypicans are being investigated in preclinical and clinical studies, with the goal of treating solid tumors that do not respond to standard therapies. | |||
TMPY-06762 |
PCDH7 Protein, Human, Recombinant (His & Avi), Biotinylated
BHPCDH |
Human | Baculovirus Insect Cells |
PCDH7, a member of protocadherins family, functions as tumor suppressor in several human cancers. The human PCDH7 gene is localized in chromosome 4p15, which is often inactivated in human cancers, including bladder cancer. The low PCDH7 expression is a potential prognostic biomarker for primary non-muscle invasive bladder cancer (NMIBC). PCDH7 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in Baculovirus insect cells with His and Avi tag. The predicted molecular weight is 95.... | |||
TMPY-04263 |
UBE2T Protein, Human, Recombinant (His)
FANCT,PIG50,ubiquitin-conjugating enzyme E2T,HSPC150 |
Human | E. coli |
Ube2T is the E2 ubiquitin-conjugating enzyme of the Fanconi anemia DNA repair pathway and it is overexpressed in several cancers, representing an attractive target for the development of inhibitors. Notably, UBE2T locates at 1q32.1, and the gain of 1q is frequently observed in a variety of cancers. For instance, UBE2T serves an important role in the growth of bladder cancer cells, and may be considered as a potential biomarker and therapeutic target for bladder cancer. | |||
TMPY-03856 |
SEZ6L2 Protein, Human, Recombinant (His)
PSK-1,seizure related 6 homolog (mouse)-like 2 |
Human | HEK293 Cells |
SEZ6L2, also known as PSK-1, belongs to the SEZ6 family. It contains 3 CUB domains and 5 Sushi (CCP/SCR) domains. SEZ6L2 may contribute to specialized endoplasmic reticulum functions in neurons.SEZ6L2 presents on the surface of lung cancer cells. SEZ6L2 should be a useful prognostic marker of lung cancers. Increased expression of this gene has been found in lung cancers, and the protein is therefore considered to be a novel prognostic marker for lung cancer. | |||
TMPK-00408 |
AXL Protein, Human, Recombinant (His & Avi), Biotinylated
AXL oncogene,EC 2.7.10.1,AI323647,Axl,JTK11,ARK,EC 2.7.10,UF... |
Human | HEK293 Cells |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers. AXL Protein, Human, Recombinant (His & Avi), Bio... | |||
TMPK-00407 |
AXL Protein, Human, Recombinant (His & Avi)
AXL oncogene,Axl,EC 2.7.10.1,Tyro7,UFO,ARK,EC 2.7.10,AI32364... |
Human | HEK293 Cells |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers. AXL Protein, Human, Recombinant (His & Avi) is e... | |||
TMPK-00472 |
AXL Protein, Cynomolgus, Recombinant (His)
Tyro7,JTK11,AI323647,AXL oncogene,EC 2.7.10.1,EC 2.7.10,UFO,... |
Cynomolgus | HEK293 Cells |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers. AXL Protein, Cynomolgus, Recombinant (His) is ex... | |||
TMPK-01510 |
HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)
NS,NS3,KRAS2,RASK2,MHC,RALD,K-Ras 2,K-RAS4B,C-K-RAS,KI-RAS,K... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01401 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)
MHC,CFC2,K-Ras 2,RALD,K-RAS4A,NS,RASK2,GTPase Kras,K-RAS2B,K... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01488 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)
K-RAS4A,MHC,GTPase Kras,K-Ras 2,KRAS2,K-RAS2B,CFC2,RASK2,RAL... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01512 |
HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)
K-Ras 2,NS,NS3,K-RAS2B,CFC2,MHC,KRAS1,GTPase Kras,K-RAS4A,KR... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01438 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
RASK2,KRAS2,KRAS1,MHC,C-K-RAS,KI-RAS,K-RAS4B,RALD,K-RAS4A,NS... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-00410 |
AXL Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated
ARK,EC 2.7.10.1,EC 2.7.10,Axl,JTK11,AXL oncogene,UFO,AI32364... |
Human | HEK293 Cells |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers. AXL Protein (Primary Amine Labeling), Human, Rec... | |||
TMPK-01399 |
HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
K-RAS2A,NS3,KRAS2,CFC2,K-RAS4B,GTPase Kras,RALD,MHC,KRAS,RAS... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01479 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
NS3,KRAS1,K-Ras 2,K-RAS2A,K-RAS2B,C-K-RAS,K-RAS4A,CFC2,KRAS2... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01473 |
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
CT1.3,MAGE-3,MZ2-D,MZ2D,HLA-A2402,HLA-A*24:02,Melanoma-assoc... |
Human | HEK293 Cells |
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa. | |||
TMPK-01493 |
HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Tetramer Protein, Human, MHC (His & Avi)
MZ2-D,Melanoma-associated antigen 3,MAGE-3,CT1.3,MZ2D |
Human | HEK293 Cells |
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa. | |||
TMPK-00865 |
TM4SF1 Protein-VLP, Human, Recombinant
TAAL6,L6,H-L6,M3S1 |
Human | HEK293 Cells |
Transmembrane-4-L-six-family-1(TM4SF1), a four-transmembrane L6 family member, is highly expressed in various pancreatic cancer cell lines and promotes cancer cells metastasis. It is upregulated in several epithelial cancers and is closely associated with poor prognosis. | |||
TMPK-01489 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)
K-RAS2A,NS3,KRAS1,KRAS2,MHC,NS,K-RAS2B,K-RAS4A,KRAS,CFC2,RAS... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01400 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
NS,KRAS1,RALD,K-RAS2A,K-RAS2B,K-RAS4A,MHC,RASK2,KRAS,GTPase ... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01471 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), FITC-Labeled
CFC2,KRAS,K-RAS4B,MHC,K-RAS2B,KRAS1,NS3,K-RAS2A,NS,K-RAS4A,R... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01407 |
HLA-A*02:01&B2M&KRAS WT (KLVVVGAGGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
KRAS2,RALD,C-K-RAS,NS3,MHC,CFC2,KRAS,KI-RAS,K-RAS4B,NS,K-RAS... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01149 |
XPNPEP2 Protein, Rat, Recombinant (His)
Xaa-Pro aminopeptidase 2,Xpnpep2,Aminoacylproline aminopepti... |
Rat | HEK293 Cells |
Aminopeptidase P2 (XPNPEP2) is a receptor for TMTP1 tumor-homing peptide. However, the biological and clinical significance of Aminopeptidase P2 in human cancers remains unknown. XPNPEP2 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 72.05 kDa and the accession number is Q99MA2. | |||
TMPK-00629 |
XPNPEP2 Protein, Mouse, Recombinant (His)
Xpnpep2,Aminoacylproline aminopeptidase,Xaa-Pro aminopeptida... |
Mouse | HEK293 Cells |
Aminopeptidase P2 (XPNPEP2) is a receptor for TMTP1 tumor-homing peptide. However, the biological and clinical significance of Aminopeptidase P2 in human cancers remains unknown. XPNPEP2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 72.24 kDa and the accession number is B1AVD1. | |||
TMPK-01495 |
HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Monomer Protein, Human, MHC (His & Avi)
Melanoma-associated antigen 3,CT1.3,MZ2D,MAGE-3,MZ2-D |
Human | HEK293 Cells |
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa. | |||
TMPK-01474 |
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi)
|
Human | HEK293 Cells |
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa. | |||
TMPK-01472 |
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Tetramer Protein, Human, MHC (His & Avi)
MAGE-3,CT1.3,Melanoma-associated antigen 3,MZ2D,MZ2-D,HLA-A*... |
Human | HEK293 Cells |
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa. | |||
TMPK-01480 |
HLA-A*02:01&B2M&Survivin (LMLGEFLKL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
IAP4,Survivin,API4,BIRC5,MHC,MHC I,EPR-1,survivin variant 3 ... |
Human | HEK293 Cells |
Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target. | |||
TMPK-01511 |
HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
GTPase Kras,K-RAS4A,KI-RAS,K-RAS4B,C-K-RAS,K-Ras 2,RASK2,K-R... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPY-00585 |
Annexin A8 Protein, Human, Recombinant (His)
ANX8,annexin A8 |
Human | E. coli |
We have previously shown that Annexin A8 (ANXA8) is strongly associated with the basal-like subgroup of breast cancers, including BRCA1-associated breast cancers, and poor prognosis; while in the mouse mammary gland AnxA8 mRNA is expressed in low-proliferative isolated pubertal mouse mammary ductal epithelium and after enforced involution, but not in isolated highly proliferative terminal end buds (TEB) or during pregnancy. ANXA8 as a potential mediator of quiescence in the normal mouse mammary ... | |||
TMPK-01516 |
HLA-A*02:01&B2M&Survivin (LMLGEFLKL) Tetramer Protein, Human, MHC (His & Avi)
IAP4,survivin variant 3 alpha,BIRC5,Survivin,EPR-1,API4,MHC ... |
Human | HEK293 Cells |
Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target. | |||
TMPY-00025 |
Mammaglobin B/SCGB2A1 Protein, Human, Recombinant (hFc)
UGB3,MGB2,LPNC,LPHC,LIPHC,secretoglobin family 2A member 1 |
Human | HEK293 Cells |
SCGB2A1 represented a novel, prognostic factor for CRC, and that expression of SCGB2A1 correlated with chemoresistance, radioresistance and cancer cell stemness. SCGB2A1 is a top differentially expressed gene in all major histological types of ovarian cancers and may represent a novel and attractive target for the immunotherapy of patients harbouring recurrent disease resistant to chemotherapy. | |||
TMPK-00927 |
ALK Protein, Mouse, Recombinant (hFc)
CD246,Anaplastic lymphoma kinase,ALK tyrosine kinase recepto... |
Mouse | HEK293 Cells |
Anaplastic lymphoma kinase (ALK) is mostly known for its oncogenic role in several human cancers. Recent evidences clearly indicate new roles of ALK and its genetic aberrations (e.g. gene rearrangements and mutations) in immune evasion, innate and cell-mediated immunity. New ALK-related immunotherapy approaches are demonstrating both preclinical and clinical promises. | |||
TMPH-03401 |
Zinc Alpha 2 Glycoprotein/AZGP1 Protein, Rat, Recombinant (His & Myc)
Azgp1,Zinc-alpha-2-glycoprotein |
Rat | E. coli |
Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. Zinc Alpha 2 Glycoprotein/AZGP1 Protein, Rat, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 39.7 kDa and the accession number is Q63678. | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIH-0181 |
Demethoxy Curcumin-d4
|
||
Demethoxy Curcumin-d4 是 Demethoxy Curcumin 的氘代化合物。Demethoxy Curcumin 的 CAS 号为 22608-11-3。Demethoxycurcumin是姜黄素的主要活性成分,有抗炎和抗癌作用。 |